About
Who We Are
Genentech (GNE), a member of the Roche group and founder of the biotechnology industry, is dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases. To solve the world's most complex health challenges, we ask bigger questions that challenge our industry and the boundaries of science to transform society. Our transformational discoveries include the first targeted antibody for cancer and the first medicine...
Updates & Highlights
Boston Herald · about 13 hours ago
Roche Genentech Innovation Center opens in Boston focused on medical research with AI, data specialists
geneonline.com · about 16 hours ago
Damon Wayans Partners With Genentech to Raise Awareness for Diabetic Macular Edema
The Joplin Globe · about 17 hours ago
Genentech and Roche Announce Grand Opening of Boston R&D Innovation Center
Recent Openings
View all 7 jobs arrow_forwardMachine Learning Engineer/Senior Machine Learning Engineer - Infra
location_on New York, NY, US
All Jobs
Machine Learning Engineer/Senior Machine Learning Engineer - Infra
location_on New York, NY, US
Culture & Mission
Benefits & Perks
Equity/Stock Options
Ownership in the company
Health Insurance
Medical, dental & vision
Remote Work
Work from anywhere flexibility
Learning Budget
Professional development
Generous PTO
Paid time off
Competitive Salary
Market-rate compensation
Tech Stack
Core Values
Innovation
Pushing boundaries in AI/ML technology
Collaboration
Working together to achieve more
Excellence
Striving for the highest quality
Impact
Making a difference in the world
Office Locations
Team
Are you on the team at Genentech?
Claim this company page to verify ownership, edit details, and respond to applicants.
Claim this company arrow_forwardNews & Press
20 recentRoche Genentech Innovation Center opens in Boston focused on medical research with AI, data specialists
Roche Genentech Innovation Center opens in Boston focused on medical research with AI, data specialists
Boston Herald · about 13 hours ago
Damon Wayans Partners With Genentech to Raise Awareness for Diabetic Macular Edema
Damon Wayans Partners With Genentech to Raise Awareness for Diabetic Macular Edema
geneonline.com · about 16 hours ago
Genentech and Roche Announce Grand Opening of Boston R&D Innovation Center
Genentech and Roche Announce Grand Opening of Boston R&D Innovation Center
The Joplin Globe · about 17 hours ago
Genentech and Roche Announce Grand Opening of Boston R&D Innovation Center
Genentech and Roche Announce Grand Opening of Boston R&D Innovation Center
businesswire.com · about 17 hours ago
Roche’s Genentech Reports Positive Phase III CELESTIMO Results for Lunsumio in Follicular Lymphoma
Roche’s Genentech Reports Positive Phase III CELESTIMO Results for Lunsumio in Follicular Lymphoma
Yahoo Finance · about 21 hours ago
‘People like the sincerity of it’: comedian Damon Wayans on humor, relatability and DME awareness in Genentech campaign
‘People like the sincerity of it’: comedian Damon Wayans on humor, relatability and DME awareness in Genentech campaign
Fierce Pharma · about 22 hours ago
Genentech’s Lunsumio-Based Regimen Significantly Improves Progression-Free Survival in Follicular Lymphoma in Phase III CELESTIMO Study
Genentech’s Lunsumio-Based Regimen Significantly Improves Progression-Free Survival in Follicular Lymphoma in Phase III CELESTIMO Study
Yahoo Finance · 1 day ago
The CMO as impact driver: A conversation with Genentech CMO Zoë Lazarre
The CMO as impact driver: A conversation with Genentech CMO Zoë Lazarre
McKinsey & Company · 1 day ago
Genentech adding new 1.25-million-square-foot R&D center in South City
Genentech adding new 1.25-million-square-foot R&D center in South City
San Mateo Daily Journal · 4 days ago
CMO of the Week: Genentech’s Zoë Lazarre
CMO of the Week: Genentech’s Zoë Lazarre
Brand Innovators · 4 days ago
Diabetic Retinopathy Market Set for Strong Expansion Through 2036 Amid Rising Investment Interest – DelveInsight | Genentech, Ionis Pharma, AstraZeneca, Regenxbio, AbbVie, Palatin Techn, Avirmax Bio
Diabetic Retinopathy Market Set for Strong Expansion Through 2036 Amid Rising Investment Interest – DelveInsight | Genentech, Ionis Pharma, AstraZeneca, Regenxbio, AbbVie, Palatin Techn, Avirmax Bio
barchart.com · 6 days ago
Roche’s Genentech Gets FDA Priority Review for Enspryng in MOGAD
Roche’s Genentech Gets FDA Priority Review for Enspryng in MOGAD
Yahoo Finance · 8 days ago
U.S. FDA Grants Priority Review for Genentech’s Enspryng for MOGAD, an Autoimmune Disease With No Approved Treatments
U.S. FDA Grants Priority Review for Genentech’s Enspryng for MOGAD, an Autoimmune Disease With No Approved Treatments
businesswire.com · 8 days ago
Ashley Magargee: Celebrating Colleen Dodson - Honoré as Genentech’s First Working for Cures Champion
Ashley Magargee: Celebrating Colleen Dodson - Honoré as Genentech’s First Working for Cures Champion
oncodaily.com · 10 days ago
Ark Clinical Research Joins Genentech’s Advancing Inclusive Research® Site Alliance
Ark Clinical Research Joins Genentech’s Advancing Inclusive Research® Site Alliance
BioSpace · 14 days ago
Ark Clinical Research Joins Genentech’s Advancing Inclusive Research® Site Alliance
Ark Clinical Research Joins Genentech’s Advancing Inclusive Research® Site Alliance
Business Wire · 15 days ago
Genentech plans massive R&D center as first step toward reimagined HQ campus
Genentech plans massive R&D center as first step toward reimagined HQ campus
The Business Journals · 15 days ago
Ark Clinical Research Joins Genentech’s Advancing Inclusive Research® Site Alliance
Ark Clinical Research Joins Genentech’s Advancing Inclusive Research® Site Alliance
Yahoo Finance · 15 days ago
Former Mobile Gaming Marketer Tiffany William Implements Fail Fast Strategy at Genentech
Former Mobile Gaming Marketer Tiffany William Implements Fail Fast Strategy at Genentech
geneonline.com · 16 days ago
Meeting Tomorrow for Genentech gRED Center, South San Francisco
Meeting Tomorrow for Genentech gRED Center, South San Francisco
sfyimby.com · 16 days ago